Integrity Alliance LLC. purchased a new position in Veeva Systems Inc. (NYSE:VEEV – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,967 shares of the technology company’s stock, valued at approximately $886,000.
A number of other institutional investors have also added to or reduced their stakes in the company. Linden Thomas Advisory Services LLC increased its stake in Veeva Systems by 0.3% in the third quarter. Linden Thomas Advisory Services LLC now owns 12,444 shares of the technology company’s stock valued at $3,707,000 after acquiring an additional 35 shares during the last quarter. Personal CFO Solutions LLC increased its stake in Veeva Systems by 3.5% in the third quarter. Personal CFO Solutions LLC now owns 1,163 shares of the technology company’s stock valued at $346,000 after acquiring an additional 39 shares during the last quarter. AFT Forsyth & Company Inc. increased its stake in Veeva Systems by 4.2% in the third quarter. AFT Forsyth & Company Inc. now owns 984 shares of the technology company’s stock valued at $293,000 after acquiring an additional 40 shares during the last quarter. Williams Jones Wealth Management LLC. increased its stake in Veeva Systems by 0.4% in the third quarter. Williams Jones Wealth Management LLC. now owns 9,419 shares of the technology company’s stock valued at $2,806,000 after acquiring an additional 40 shares during the last quarter. Finally, CIBC Asset Management Inc increased its stake in Veeva Systems by 0.7% in the third quarter. CIBC Asset Management Inc now owns 6,821 shares of the technology company’s stock valued at $2,032,000 after acquiring an additional 45 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.
Insider Buying and Selling at Veeva Systems
In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares of the company’s stock, valued at approximately $506,296.92. This trade represents a 18.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 10.60% of the company’s stock.
More Veeva Systems News
- Positive Sentiment: Veeva said Kindeva is adopting Veeva Quality Cloud to unify manufacturing operations across its global network, highlighting another enterprise customer win and potential for recurring software revenue. Veeva Quality Cloud Advances Manufacturing Operations for Kindeva
- Positive Sentiment: Teva Pharmaceuticals committed to Veeva Vault CRM globally, a meaningful commercial deal that supports Veeva’s customer expansion in pharma. Teva Pharmaceuticals Commits to Veeva Vault CRM
- Positive Sentiment: Merck KGaA, Darmstadt, Germany also selected Veeva Vault CRM worldwide, further validating Veeva’s platform and suggesting healthy enterprise adoption trends. Merck KGaA, Darmstadt, Germany Selects Veeva Vault CRM Worldwide
- Positive Sentiment: Veeva launched Falcon, an agentic platform for drug development workflows, which could strengthen its AI story and expand the value of its Development Cloud products. Veeva Announces Falcon, an Agentic Platform and Standard Agents to Deliver Agentic Labor in Drug Development
- Neutral Sentiment: Veeva was highlighted in a Zacks note as a trending stock and another report said analysts rate it a “Moderate Buy,” which may support investor interest but does not change fundamentals by itself. Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Analyst Ratings Changes
A number of research firms recently commented on VEEV. TD Cowen reduced their target price on Veeva Systems from $380.00 to $300.00 and set a “buy” rating on the stock in a research note on Thursday, March 5th. Royal Bank Of Canada reduced their price objective on Veeva Systems from $330.00 to $275.00 and set an “outperform” rating on the stock in a research note on Thursday, March 5th. Zacks Research lowered shares of Veeva Systems from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 14th. Citigroup lowered shares of Veeva Systems from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $291.00 to $176.00 in a report on Friday, April 10th. Finally, Wells Fargo & Company dropped their target price on shares of Veeva Systems from $333.00 to $317.00 and set an “overweight” rating for the company in a report on Thursday, March 5th. Sixteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $276.52.
Read Our Latest Report on Veeva Systems
Veeva Systems Price Performance
Shares of VEEV opened at $164.26 on Friday. Veeva Systems Inc. has a one year low of $148.05 and a one year high of $310.50. The company has a 50-day simple moving average of $166.59 and a two-hundred day simple moving average of $199.95. The firm has a market capitalization of $26.83 billion, a PE ratio of 30.36, a price-to-earnings-growth ratio of 0.70 and a beta of 0.92.
Veeva Systems (NYSE:VEEV – Get Free Report) last issued its quarterly earnings data on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Veeva Systems had a net margin of 28.44% and a return on equity of 13.80%. The business had revenue of $835.95 million during the quarter, compared to analyst estimates of $810.95 million. During the same period last year, the business posted $1.74 earnings per share. Veeva Systems’s quarterly revenue was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. Analysts expect that Veeva Systems Inc. will post 6.45 EPS for the current fiscal year.
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Stories
- Five stocks we like better than Veeva Systems
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
